Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-04-05
1996-07-02
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514645, A61K 3113
Patent
active
055322190
ABSTRACT:
This invention pertains to the novel use of 4,4'-diaminodiphenylsulfone and its didextrose sulfonate derivative and other closely related sulfones in the prevention and treatment of dementia (Alzheimer's disease). A method of preventing and treating dementia in a human being suffering from dementia which comprises administering to the human being a therapeutic amount of a substance selected from the group consisting of 4,4'-diaminodiphenylsulfone, its didextrose sulfonate derivative, and sulfoxone, sulfetrone and thiazolsulfone, and therapeutically acceptable salts thereof.
REFERENCES:
patent: 4791099 (1988-12-01), Aroonsakul
patent: 4855308 (1989-08-01), Kester et al.
"The Merck Index", 1989, Merck & C., Inc., Rahway, N.J., U.S.A., #2820, 4357, 8667, 8664, 8947, 9237.
"The Merck Index", 10th Ed., #2808, 4324 1983.
Capstick et al., 84CA:993111W, 1976.
Stendahl et al., 98CA:1914689, 1983.
P. L. McGeer et al., Dementia, vol. 3, No. 3, 1992 pp. 146-149, "Prevalence of Dementia Amongst Elderly Japanese with Leprosy: Apparent Effect of Chronic Drug Therapy".
Shibayama, H., et al., "Prevalence of Dementia in a Japanese Elderly Population", Actua. Psychiat., Scand. 1986; 74:144-51.
Zuidema, J., et al., "Clinical Pharmacokinetics of Dapsone", Clin. Pharmacokinetics 1986; 11:299-315.
Boesen., P., et al., "Dapsone in Temporal Arteritis and Polymaglia Rheumatica", J. Rheumatol. 1988; 15:879-80.
Lindskov, R. and Reyman F., "Dapsone in the Treatment of Cutaneous Lupus Erythematosus", Dermatologia 1986; 172:214-17.
Sharquie K. E., "Suppression of Behcet's Disease with Dapsone", Brit. J. Dermatol. 1984; 110:493-4.
Guillevin L., "Treatment of Polyarteritis Nodosa with Dapsone", Scand. J. Rheumatol. 1986; 15:95-6.
Gabriel S. E., et al., "Rifampin Therapy in Rheumatol Arthritis", J. Rheumatoid. 1990; 17:163-6.
Van Saane P. and Timmerman H., "Pharmacohistochemical Aspects of Leprosy. Recent Developments and Prospects for New Drugs", Pharm. Weekbl. 1989; 11:3-8 Abstract.
McGeer P. L., et al., "Anti-inflammatory Drugs and Alzhemier's Disease", Lancet 1990; 335:1037.
Evans D. A., et al., "Prevalence of Alzheimer Disease in a Community Population of Older Persons", JAMA 1989; 262:2551-6.
Mortimer J. A., "Alzheimer's Disease and Dementia: Prevalence and Incidence", In: Reisberg B (ed) Alzheimer's Disease, Glencoe, Free Press, 1983.
Sulkava R., et al., "Prevalence of Severe Dementia in Finland", Neurology 1985; 35:1025-9.
Zhang M., et al., "The Prevalence of Dementia and Alzheimer's Disease in Shanghai, China: Impact of Age, Gender and Education", Ann Neurol. 1990: 27:428-37.
Itagaki S., et al., "Presence of T-cytotoxic Suppressor and Leucocyte Common Antigen Positive Cells in Alzheimer's Disease Brain Tissue", Neurosci. Lett. 1988; 91:259-64.
McGeer P. L., et al., "Reactive Microglia in Patients with Senile Dementia of the Alzheimer Type are Positive for the Histocompatibility Glycoprotein, HLA-DR.", Neurosci. Lett. 1987; 79:195-200.
Rogers J., et al., "Expression of Immune System-Associated Antigen by Cells of the Human Central Nervous System. Relationship to the Pathology of Alzheimer's Disease", Neurobiol. Aging 1988; 9:330-49.
McGeer P. L., et al., "Immune System Response in Alzheimer's Disease", Can. J. Neurol. Sci. 1989; 16:516-27.
McGeer P. L., et al., "Activation of hte Classical Complement Pathway in Brain Tissue of Alzheimer Patients", Neurosci. Lett. 1989; 107:341-6.
Akiyama H. and McGeer P. L., "Brain Microglia Constitutively Express .beta.-2 Integrins", J. Neurolimmunol. 1990; 30:81-93.
Eikelenboom P., et al., "Complement Activation in Amyloid Plaques in Alzheimer's Dementia", Virchows Arch. (Cell Pathol.) 1989; 56:259-62.
Cowdry, E. V. and Ruangsivi C., "Influence of Promin, Starch and Heptaldehyde on Experimental Leprosy in Rats", Arch. Pathol. 32:632, 1941.
Harada Nobua
Kimura Horoshi
McGeer Edith G.
McGeer Patrick L.
Schulzer Michael
The University of British Columbia
Travers Russell
LandOfFree
Dapsone and promin for the treatment of dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dapsone and promin for the treatment of dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dapsone and promin for the treatment of dementia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506433